BTG Plc Company Profile - Aug 07, 2011

Document Sample
BTG Plc Company Profile - Aug 07, 2011 Powered By Docstoc
					Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   BTG Plc
                                                                                         440 Wheelers Farms Road
                                                                                         Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in Pounds Sterling

                                 Wright Quality Rating:BBNN                                Key Data

   BTG Plc is a United Kingdom-based company. The principal activity of the Company        Ticker:
   is the development and commercialisation of life science technologies. It licenses,     BGC
   develops and commercializes pharmaceuticals, and has a range of research and
   development programmes focusing oncology, neurological and other disorders. The         2011 Sales:
   Company manufactures and sells pharmaceutical products, and drugs for use in the
                                                                                           111,400,000
   treatment of human diseases. The Company's subsidiaries include BTG International
   (Holdings) Ltd, Provensis Ltd, BTG International Ltd, BTG Employee Share Schemes
   Ltd, BTG Investment (Holdings) Ltd, BTG International Inc., British Technology Group    Major Industry:
   Inter-Corporate Licensing Ltd, Protherics Ltd, Protherics Medicines Development Ltd,    Miscellaneous
   Protherics Inc., Enact Pharma Ltd, Protherics UK Ltd, BTG Australasia Pty Ltd,
   Protherics Utah Inc. and Protherics Salt Lake City Inc.                                 Sub Industry:
                       Stock Chart                                    Officers             Service Organizations
                                                              Non Executive Chairman
                                                               Dr. John Robert Brown       Country:
                                                                                           United Kingdom
                                                          Executive Director & Chief
                                                                 Executive                 Currency:
                                                               Dr. Louise Makin
                                                                                           Pounds Sterling

                                                               Chief Financial Officer
                                                                                           Fiscal Year Ends:
                                                                 Rolf B. Soderstrom
                                                                                           March
                                                                    Secretary
                                                                  Paul Mussenden           Employees
                                                                                           331

                                                                                           Exchanges:
				
DOCUMENT INFO
Description: BTG Plc is a United Kingdom-based company. The principal activity of the Company is the development and commercialisation of life science technologies. It licenses, develops and commercializes pharmaceuticals, and has a range of research and development programmes focusing oncology, neurological and other disorders. The Company manufactures and sells pharmaceutical products, and drugs for use in the treatment of human diseases. The Company's subsidiaries include BTG International (Holdings) Ltd, Provensis Ltd, BTG International Ltd, BTG Employee Share Schemes Ltd, BTG Investment (Holdings) Ltd, BTG International Inc., British Technology Group Inter-Corporate Licensing Ltd, Protherics Ltd, Protherics Medicines Development Ltd, Protherics Inc., Enact Pharma Ltd, Protherics UK Ltd, BTG Australasia Pty Ltd, Protherics Utah Inc. and Protherics Salt Lake City Inc.
BUY THIS DOCUMENT NOW PRICE: $24.95 100% MONEY BACK GUARANTEED
PARTNER Wright Investors' Service
Wright Investors' Service is an internationally recognized investment management and financial advisory firm headquartered in Milford, Connecticut. For more than 40 years, Wright has used well-defined and sophisticated investment strategies to help institutions, plan sponsors, bank trust departments, trust companies and individual investors achieve their financial objectives through a sensible approach to managing assets that balances risk and return.